t&#45

2 trials

Sponsors

None, Oxform Immunotec

Conditions

Kidney transplantation Latent TB infection IGRA kidney transplantationtherapy&#45

Phase 1

Role of Interferon-gamma Release Assays for Screening and Monitoring of Latent Tuberculosis Infection in Kidney Transplant Recipients

RecruitingTCTR20200928005

Oxform ImmunotecKidney transplantation Latent TB infection IGRA kidney transplantation

Start: 2020-09-01Target: 100Updated: 2026-08-03

Unknown Phase

Prognostic parameter in patients having therapy-related myeloid neoplasms after peptide receptor radionuclide therapy (PRRT) and peptide receptor radioligand therapy (PRLT) over 20 yearsâ€™ experience

Active, not recruitingTCTR20200428005

Nonetherapy&#45

Start: 2004-04-01Target: 386Updated: 2026-08-03